PRIMARY IMMUNODEFICIENCY
Clinical trials for PRIMARY IMMUNODEFICIENCY explained in plain language.
Never miss a new study
Get alerted when new PRIMARY IMMUNODEFICIENCY trials appear
Sign up with your email to follow new studies for PRIMARY IMMUNODEFICIENCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New antibody shot study aims to help Immune-Compromised patients
Disease control OngoingThis study tests a medicine called IgPro20, which is given as a shot under the skin, in adults with primary immunodeficiency (PID) who have never received antibody therapy before. The goal is to see how the body processes the drug and whether it is safe. Only 8 people will take p…
Matched conditions: PRIMARY IMMUNODEFICIENCY
Phase: PHASE4 • Sponsor: CSL Behring • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
Skin biopsies could pave way for future gene therapies
Knowledge-focused ENROLLING_BY_INVITATIONThis study collects small skin samples from up to 200 people with immune system disorders and healthy volunteers. Researchers will use these samples to grow skin cells in the lab, which may help develop new gene therapies for immune diseases in the future. Participants must be en…
Matched conditions: PRIMARY IMMUNODEFICIENCY
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated May 26, 2026 03:52 UTC